Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Ra Capital Management, L.P. | Director, 10%+ Owner | $97.7M | Jun 20, 2024 | ||
Oxford Science Enterprises plc | 10%+ Owner | $57.1M | May 10, 2022 | ||
James E. Flynn | Possible Member of 10% Group, 10%+ Owner | $3.97M | May 10, 2022 | ||
James G. McArthur | President and CEO, Director | $7.06K | Mar 1, 2024 | ||
Niels Svenstrup | SVP, Chem. Mfg & Controls | $0 | -$134K | -100% | May 17, 2024 |
Michelle L. Mellion | Chief Medical Officer | $0 | -$906K | -100% | Jul 24, 2024 |
Joshua Resnick | Director | Jun 20, 2024 | |||
Paul Streck | EVP, Head of R&D | Aug 19, 2024 | |||
Heidi Henson | Director | Jun 20, 2024 | |||
Laurie Keating | Director | Jun 20, 2024 | |||
Mary Beth DeLena | General Counsel | Jan 15, 2024 | |||
Habib J. Dable | Director | Jun 20, 2024 | |||
Sonia Bracegirdle | Sr. VP Strategy & Operations | May 6, 2022 | |||
Christopher Ashton | Director | Jun 20, 2024 | |||
Noel Donnelly | Chief Financial Officer | Mar 1, 2024 | |||
Jaya Goyal | EVP, Res. & Preclin. Dev. | Mar 24, 2023 | |||
Howard Mayer | Director | Jun 20, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|